Edition:
United States

Keryx Biopharmaceuticals Inc (KERX.OQ)

KERX.OQ on NASDAQ Stock Exchange Capital Market

3.36USD
12 Dec 2018
Change (% chg)

$-0.07 (-2.04%)
Prev Close
$3.43
Open
$3.44
Day's High
$3.46
Day's Low
$2.96
Volume
929,249
Avg. Vol
274,553
52-wk High
$5.97
52-wk Low
$2.48

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Michael Rogers

58 2017 Chairman of the Board

Jodie Morrison

43 2018 Interim Chief Executive Officer, Director

Scott Holmes

44 2015 Chief Financial Officer, Treasurer

Christine Carberry

57 2017 Chief Operating Officer

John Neylan

65 2015 Chief Medical Officer